Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nonconvulsive status epilepticus due to ifosfamide.

Saadettin Kilickap1, Mustafa Cakar, Ibrahim K Onal

  • 1Department of Medical Oncology, Hacettepe University Institute of Oncology, Sihhiye, Ankara, Turkey. skilickap@yahoo.com

The Annals of Pharmacotherapy
|February 2, 2006
PubMed
Summary

Nonconvulsive status epilepticus (NCSE) is a rare but serious neurotoxicity associated with ifosfamide chemotherapy. Early recognition and treatment with diazepam and levetiracetam are crucial for managing this condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effectiveness and probability of full disease control with canakinumab in familial Mediterranean fever: real-world data from the AIDA Network.

Rheumatology (Oxford, England)·2026
Same author

Ophthalmic involvement in VEXAS syndrome and its influence on mortality: insights from the international AIDA network registry.

Frontiers in immunology·2026
Same author

Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry.

Seminars in arthritis and rheumatism·2026
Same author

Comment on: Factors associated with anakinra effectiveness and risk of infection in crystal-related flares.

Rheumatology (Oxford, England)·2026
Same author

Predictive Factors for Relapse in Still's Disease: A Retrospective Cohort Study of Clinical and Laboratory Biomarkers.

Clinical and translational science·2026
Same author

Validity and reliability of the Turkish version of the hand scleroDerma lived experience scale.

Journal of bodywork and movement therapies·2026

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Background:

  • Ifosfamide is a widely used chemotherapeutic agent.
  • Neurotoxicity is a known adverse effect of ifosfamide.
  • Nonconvulsive status epilepticus (NCSE) is a form of epileptic disorder characterized by altered consciousness without overt convulsive activity.

Observation:

  • Two patients receiving ifosfamide-based chemotherapy developed symptoms consistent with NCSE, including confusion, lethargy, and speech deterioration.
  • The onset of symptoms occurred on day 3 of ifosfamide treatment in both cases.
  • Both patients responded promptly to intravenous diazepam and were subsequently treated with levetiracetam for maintenance therapy.

Findings:

  • This report adds two cases to the previously documented instances of ifosfamide-induced NCSE, highlighting its potential occurrence.

Related Experiment Videos

  • The study suggests that NCSE is a probable neurotoxic effect of ifosfamide, as indicated by the Naranjo probability scale assessment.
  • Levetiracetam appears to be a viable option for maintenance antiepileptic therapy following initial treatment with diazepam.

    • Implications:

    • Clinicians should maintain a high index of suspicion for NCSE in patients presenting with altered consciousness during ifosfamide therapy.
    • Prompt recognition and management of ifosfamide-induced NCSE can potentially prevent severe neurological sequelae.
    • Further research is warranted to elucidate the precise mechanisms of ifosfamide neurotoxicity and optimize treatment strategies.